Best Use of the Tyrosine Kinase Inhibitors in Progressive Differentiated Thyroid Cancer: Discussion.

Tuttle, R M

Best Use of the Tyrosine Kinase Inhibitors in Progressive Differentiated Thyroid Cancer: Discussion. [electronic resource] - Clinical advances in hematology & oncology : H&O May 2016 - 12-3 p. digital

Publication Type: Interview

1543-0790


Animals
Antineoplastic Agents--pharmacology
Disease Progression
Drug Resistance, Neoplasm
Genetic Testing
Genetic Variation
Humans
Neoplasm Grading
Neoplasm Metastasis
Protein Kinase Inhibitors--pharmacology
Protein-Tyrosine Kinases--antagonists & inhibitors
Thyroid Neoplasms--diagnosis
Treatment Outcome